NCT04496154View on ClinicalTrials.gov

"Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry Bad Cholesterol in the Blood"

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 5, 2013

Primary Completion Date

January 22, 2020

Study Completion Date

February 24, 2020

Conditions
Type 2 DiabetesInsulin Sensitivity/ResistanceInflammatory ResponseFatty Acids, Omega-3
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)

Triple Strength Omega-3 from Webber Naturals

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

May Faraj, PDt, PhD

OTHER

NCT04496154 - "Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry Bad Cholesterol in the Blood" | Biotech Hunter | Biotech Hunter